Effects of glucocorticoids on interstitial glucose concentrations in individuals with hematologic cancer and without known diagnosis of diabetes: a pilot study-Reference-Cited by-同舟云学术

Effects of glucocorticoids on interstitial glucose concentrations in individuals with hematologic cancer and without known diagnosis of diabetes: a pilot study

Published:2022 Issue: Volume:20 Page:
ISSN:1679-4508
Container-title:einstein (São Paulo)
language:en
Short-container-title:

Author:

Toyoshima Marcos Tadashi Kakitani^ORCID,Cukier Priscilla^ORCID,Souza Alexandre Barbosa Câmara de^ORCID,Pereira Juliana^ORCID,Hoff Ana Oliveira^ORCID,Nery Marcia^ORCID

Publisher

Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein

Subject

General Medicine

Reference37 articles.

1. Diabetes and cancer: a consensus report;Giovannucci;Diabetes Care,2010

2. Cancer with diabetes: prevalence, metabolic control, and survival in an academic oncology practice;Karlin;Endocr Pract,2012

3. Hospitalization as an opportunity to optimize glycemic control in oncology patients;Hiestand;Curr Diab Rep,2019

4. Retrospective review of the incidence of monitoring blood glucose levels in patients receiving corticosteroids with systemic anticancer therapy;Rowbottom;Ann Palliat Med,2015

5. Glucocorticoid-induced diabetes mellitus: an important but overlooked problem;Suh;Endocrinol Metab (Seoul),2017

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Important aspects of carbohydrate metabolism disorders development in hematology/oncology patients during therapy with glucocorticosteroids: a review of the literature;Oncohematology;2024-04-02

2. Fructosamine and glycated hemoglobin as biomarkers of glycemic control in people with type 2 diabetes mellitus and cancer (GlicoOnco study);Clinics;2023-01